<?xml version="1.0" encoding="UTF-8"?>
<fig id="Fig2">
 <label>Fig. 2</label>
 <caption>
  <title>Polymorphic SVAs were associated with markers of PD progression in the PPMI cohort.</title>
  <p>
   <bold>a</bold> PD individuals with the AA genotype of SVA_67 had a significantly higher ipsilateral caudate/putamen CDR at both 12 and 24 months compared to those with PA and PP genotypes. 
   <bold>b</bold> PD individuals with the AA genotype of SVA_11 had a significantly higher MDS-UPDRS part II score at 36 months compared to those with PA and PP genotypes. 
   <bold>c</bold> PD individuals with the PA genotype of SVA_24 had a significantly higher Hoehn and Yahr score at 36 months compared to those with AA and PP genotypes. 95% confidence intervals are represented by the blue bar. *
   <italic>p</italic> &lt; 0.05, **
   <italic>p</italic> &lt; 0.01 and ***
   <italic>p</italic> &lt; 0.001 (Tukey adjusted p values are reported).
  </p>
 </caption>
 <graphic xlink:href="41531_2021_189_Fig2_HTML" id="d32e1776" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</fig>
